Ketamine Clinics Market, By Treatment (Anxiety, Depression and PTSD), By Therapy (Online Therapy and On-Site Therapy), By Referral Source (Primary Care Physicians, Online Advertising and Mental Health Professionals), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Ketamine clinics market size was valued at USD 8,704.5 Million in 2022, expanding at a CAGR of 11.3% from 2023 to 2030.
Ketamine clinics are defined as hospitals that engage in therapeutic purposes by administering ketamine, a dissociative anesthetic, and analgesic drug. Moreover, as a potential treatment ketamine has drawn interest for numerous mental health conditions, especially anxiety disorders, post-traumatic stress disorder (PTSD), and treatment-resistant depression. In line with this, ketamine has shown promise in offering quick relief, generally within hours, while traditional antidepressant medications may require weeks or months to show results. Furthermore, ketamine clinics traditionally provide intravenous (IV) ketamine infusions or, in other cases, other forms of ketamine administration, including oral lozenges and nasal sprays.
Ketamine Clinics Market- Market Dynamics
- Research & Clinical Trials and Increasing Demand Ketamine will boost the market growth
The increasing prevalence of mental health conditions coupled with limitations of traditional treatments, in turn; there has been a rising demand for alternative therapies such as ketamine. Moreover, with the positive outcomes in early studies, more clinical trials and investigation is required to determine the long-term safety and effectiveness of ketamine for the treatment of mental health concern. In addition, as research develops the view and acceptance of ketamine as a treatment option may shift. Furthermore, some established medical practices and mental health clinics have started including ketamine treatment as part of their product line, as ketamine therapy gains more recognition. However, insurance coverage for ketamine therapy can be a major challenge, which may restrain the ketamine clinic\'s market growth over the forecast period.
Ketamine Clinics Market- Key Insights
- As per the analysis shared by our research analyst, the ketamine clinics market is estimated to grow annually at a CAGR of around 11.3% over the forecast period (2023-2030)
- The ketamine clinics industry is projected to grow at a significant rate due to the rising prevalence of mental health conditions and limitations of traditional treatments
- Based on therapy segmentation, on-site therapy was predicted to show maximum market share in the near future
- Based on treatment segmentation, depression was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Ketamine Clinics Market- Segmentation Analysis:
The global ketamine clinics market is segmented on the basis of treatment, therapy, referral source, and region.
The market is divided into three categories based on treatment: anxiety, depression, PTSD, and others. The depression segment is likely to possess the largest revenue share owing to the growing number of adults with severe major depression. Additionally, in the medical community ketamine has gained attention for its potential use in treating depression. Moreover, ketamine clinics have emerged as specialized centers that provide ketamine therapy for patients who have suffered from depression or other mood disorders.
The market is divided into two categories based on therapy: online therapy and on-site therapy. The on-site therapy segment is likely to possess the market share over the forecast period. For mental health disorders increasing acceptance of ketamine therapy is led to an expansion of ketamine, further driving the segment growth. Additionally, mental health professionals also provide therapy sessions for patients including counselors, psychologists, and psychiatrists.
The market is divided into three categories based on referral sources: primary care physicians, online advertising, and mental health professionals. The primary care physicians segment is expected to dominate the market share. PCPs are suitable to diagnose and treat numerous medical conditions, such as mental health disorders like anxiety and depression. Moreover, primary care physicians may send their patients to ketamine clinics when primary care physicians think ketamine therapy might be helpful for severe or treatment-resistant depression or other mental health concerns. Thereby such factors may propel the segment growth.
Ketamine Clinics Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Ketamine Clinics Market- Competitive Landscape:
The market is witnessing significant growth, driven by factors including the ongoing opioid crisis, rising mental health awareness, and a large number of ketamine clinics across the globe. Moreover, ketamine clinics industries are focusing on numerous strategies such as partnerships, launching new services, mergers & acquisitions, and expansions to expand their market presence worldwide. Furthermore, as more providers have entered the space the ketamine clinics market has become more competitive. For instance, in April 2023, Mindbloom announced a partnership with SHIFT to provide at-home ketamine therapy as a benefit to its employees. Additionally, through this partnership, all SHIFT employees will have access to at-home ketamine therapy for a fraction of the normal price through Mindbloom.
Recent Developments:
- For instance, in January 2022, Delic Holdings Corp announced its subsidiary, Ketamine Wellness Centers (KWC), has officially expanded operations into Utah with the opening of its Salt Lake City location.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL KETAMINE CLINICS MARKET KEY PLAYERS
- Arevipharma GmbH
- Biotechnica Pharma Global (BPG)
- NY Ketamine Infusions
- Core One Labs
- Johnson & Johnson
- Pfizer
- Field Trip Health and Wellness Ltd.
- Save Minds
- Ember
- UQUIFA
- Mindbloom
- Ketamine Clinics
- Vitalitas Denver Ketamine Clinic
GLOBAL KETAMINE CLINICS MARKET, BY TREATMENT
- Anxiety
- Depression
- PTSD
- Others
GLOBAL KETAMINE CLINICS MARKET, BY THERAPY
- Online Therapy
- On-Site Therapy
GLOBAL KETAMINE CLINICS MARKET, BY REFERRAL SOURCE
- Primary Care Physicians
- Online Advertising
- Mental Health Professionals
GLOBAL KETAMINE CLINICS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Ketamine Clinics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Ketamine Clinics Market Snippet by Treatment
2.1.2. Ketamine Clinics Market Snippet by Therapy
2.1.3. Ketamine Clinics Market Snippet by Referral Source
2.1.4. Ketamine Clinics Market Snippet by Country
2.1.5. Ketamine Clinics Market Snippet by Region
2.2. Competitive Insights
3. Ketamine Clinics Key Market Trends
3.1. Ketamine Clinics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Ketamine Clinics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Ketamine Clinics Market Opportunities
3.4. Ketamine Clinics Market Future Trends
4. Ketamine Clinics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Ketamine Clinics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Ketamine Clinics Market Landscape
6.1. Ketamine Clinics Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Ketamine Clinics Market – By Treatment
7.1. Overview
7.1.1. Segment Share Analysis, By Treatment, 2022&2030 (%)
7.1.2. Anxiety
7.1.3. Depression
7.1.4. PTSD
7.1.5. Others
8. Ketamine Clinics Market – By Therapy
8.1. Overview
8.1.1. Segment Share Analysis, By Therapy, 2022&2030 (%)
8.1.2. Online Therapy
8.1.3. On-Site Therapy
9. Ketamine Clinics Market – By Referral Source
9.1. Overview
9.1.1. Segment Share Analysis, By Referral Source, 2022&2030 (%)
9.1.2. Primary Care Physicians
9.1.3. Online Advertising
9.1.4. Mental Health Professionals
10. Ketamine Clinics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Ketamine Clinics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Ketamine Clinics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Ketamine Clinics Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Ketamine Clinics Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Ketamine Clinics Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Ketamine Clinics Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Arevipharma GmbH
11.2.2. Biotechnica Pharma Global (BPG)
11.2.3. NY Ketamine Infusions
11.2.4. Core One Labs
11.2.5. Johnson & Johnson
11.2.6. Pfizer
11.2.7. Field Trip Health and Wellness Ltd.
11.2.8. Save Minds
11.2.9. Ember
11.2.10. UQUIFA
11.2.11. Mindbloom
11.2.12. Ketamine Clinics
11.2.13. Vitalitas Denver Ketamine Clinic
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us